Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Immune profiling in patients with multiple myeloma treated with cellular therapies

Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, discusses the importance of immune profiling in patients with multiple myeloma early on in disease evolution, especially in the era of novel cellular therapies. Additionally, Dr Paiva elaborates on the value of using biallelic events in BCMA and GPRC5D as biomarkers for immunotherapy resistance. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.